ロード中...
Azithromycin and the microbiota of cystic fibrosis sputum
BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...
保存先:
| 出版年: | BMC Microbiol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8008652/ https://ncbi.nlm.nih.gov/pubmed/33784986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02159-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|